Search
for
Sort by
Research 30 of 1000+
- Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?
- Modulation der Hitzesensitivität im Prostatakarzinom in vitro: Der Einfluss der Androgenachse
- COVID-19 pandemic: what about the gonads?
- Androgens in women
- Nociceptive and Nonnociceptive Roles of TRPV3 and Its “Druggability”
- Androgen receptor modulators: a review of recent patents and reports (2012-2018)
- A Comprehensive Review on Alopecia: Mechanisms, Classification, and Therapeutic Strategies
- A Comprehensive Review on Alopecia: Mechanisms, Classification, and Therapeutic Strategies
- Androgens and Parkinson’s disease: the role in humans and in experiment
- Immunohistochemical Evaluation of Androgen Receptor and Nerve Structure Density in Human Prepuce from Patients with Persistent Sexual Side Effects after Finasteride Use for Androgenetic Alopecia
- Discovery of an Androgen Receptor Degrader Featuring a Pyridazinyl Glutarimide CRBN-Binding Motif for Transdermal Treatment of Androgenetic Alopecia
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Slow progress in prostate cancer
- Female Androgenetic Alopecia: An Update on Diagnosis and Management
- Thiohydrazides in the Synthesis of Functionalized Extranuclear Heterosteroids
- Androgen modulation of Wnt/β-catenin signaling in androgenetic alopecia
- Cross-kingdom delivery and putative gene modulation of androgen pathways by plant-derived exosome-like nanoparticles from polygoni multiflori radix promotes hair growth via miRNA cargo
- Synthesis and application of clinically approved small-molecule drugs targeting androgen receptor
- Pharmacologic Modulation of Sebaceous Gland Activity: Mechanisms and Clinical Applications
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- COVID‐19, androgens, and androgenic alopecia
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- Modulating metal-organic frameworks by surface engineering of stearic acid modification for follicular drug delivery and enhanced hair growth promotion
- Targets to treat androgen excess in polycystic ovary syndrome
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Meloside A Protects Dermal Papilla Cells from DHT-Induced Damage via Androgen Receptor Modulation
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- Adult polycystic ovary syndrome begins in childhood
- INSULIN-LOWERING MEDICATIONS IN POLYCYSTIC OVARY SYNDROME
- Association of long-term 5α-reductase inhibitor use with survival in men with renal cell carcinoma: a nationwide population-based cohort study